CCRM’s founding industry consortium represents key sectors of the Regenerative Medicine (RM) industry – pharmaceutical, devices, reagents, tools, biomaterials and cell therapies. Despite their differences, they all have the same objective: to utilize the translational platforms developed by CCRM to enable new opportunities and to address real-life bottlenecks in their RM businesses. The industry consortium consists of large multinationals, small-medium enterprises (SME) and emerging biotechnology companies. The industry consortium provides market knowledge and a ready supply of global receptors for technologies and products generated by CCRM and its partners.
(click logo to visit site)